Loading...
Powered By
8 items
2025-06-29
Cytori Cell Research Institute, Inc. announced that they will report Q1, 2026 results on Aug 14, 2025
2025-05-16
Cytori Cell Research Institute, Inc., Annual General Meeting, Jun 27, 2025.
2025-05-14
Cytori Cell Research Institute, Inc. expected to report Q1 2026 results on August 14, 2025. This event was calculated by S&P Global (Created on May 14, 2025).
2025-03-19
Cytori Cell Research Institute, Inc. announced that they will report fiscal year 2025 results on May 15, 2025
2025-01-03
Cytori Cell Research Institute, Inc. expected to report Fiscal Year 2025 results on May 13, 2025. This event was calculated by S&P Global (Created on January 3, 2025).
2025-01-03
Cytori Cell Research Institute, Inc. announced that they will report Q3, 2025 results on Feb 14, 2025
2024-10-08
Cytori Cell Research Institute, Inc. announced that they will report Q2, 2025 results on Nov 14, 2024
2024-09-25
Samty Hotel Management K.K. agreed to acquire Fractal Hospitality Co., Ltd. from Cytori Cell Research Institute, Inc. (TSE:3750) on September 24, 2024. As part of the acquisition, Samty Hotel is acquiring 100% stake corresponding to 1200 shares in Fractal Hospitality. Prior to the transaction, Shinji Ezure, Representative Director of Fractal Hospitality Co., Ltd has transferred 10% stake corresponding to 108 shares to Cytori Cell Research Institute. The transaction has been approved by the board of directors of Cytori Cell Research Institute. The transaction is expected to close on September 30, 2024.
2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | 2023Q4 | 2023Q3 | |
|---|---|---|---|---|---|---|---|---|
Total Revenues | 89 | 122 | 264 | 789 | 1,127 | 1,560 | 1,904 | 1,834 |
Pretax Income Excl.Unusual Items | -776 | -861 | -1,445 | -1,392 | -1,461 | -1,394 | -836 | -845 |
Total Assets | 735 | 3,537 | 4,886 | 5,146 | 5,365 | 5,816 | 13,739 | 13,598 |
Total Liabilities | 247 | 2,907 | 2,868 | 2,809 | 2,834 | 3,022 | 11,636 | 11,386 |
Cash & Cash Equivalents | 369 | 255 | 443 | 521 | 600 | 1,038 | 716 | 658 |
Total Common Equity | 488 | 630 | 2,018 | 2,337 | 2,527 | 2,790 | 2,099 | 2,208 |
Book Value Per Share (BVPS) | 54.66 | 70.56 | 226.02 | 261.75 | 283.03 | 312.49 | 235.09 | 247.3 |
Net Change in Cash | -782 | 313 | 365 | -352 | ||||
Capital Expenditure | -8 | -21 | -17 | -46 |
Cytori Cell Research Institute revealed its financial results for the second quarter of 2025 on August 14, 2025, having revenues of 6M yen and net income of 69M yen, indicating a notable 84.6% decrease in revenue, with a transition from a loss per share in the same quarter last year to a profit per share in the current quarter.
and it trades at 17.11 times price to book ratio, which is higher than the industry average (P/B 0.84).